Delayed breast cancer surgery in HER2 positive breast cancer

被引：0

作者：

Hur, Ho ^{[1
]}

Le, Amy ^{[2
]}

Chang, Helena R. ^{[2
]}

机构：

[1] Yonsei Univ, Med Ctr, Seoul, South Korea

[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Revlon UCLA Breast Ctr, Los Angeles, CA 90095 USA

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS19-P1-20-13

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1-20-13

引用

页数：2

共 50 条

[1] Delayed chemotherapy in HER2 positive breast cancer
Hur, Ho
Le, Amy
Chang, Helena R.
CANCER RESEARCH, 2020, 80 (04)
[2] HER2 positive breast cancer
Gianni, Luca
Bianchini, Giampaolo
CANCER RESEARCH, 2023, 83 (05)
[3] IMMUNOTHERAPY FOR HER2 POSITIVE BREAST CANCER
Vaidya, T. R.
Ait-Oudhia, S.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S20 - S20
[4] Her2 positive breast cancer: practices
Campone, Mario
Berton-Rigaud, Dominique
Bourbouloux, Emmanuelle
Sophie, Sadot
Zanetti, Alain
Frenel, Jean-Sebastien
BULLETIN DU CANCER, 2011, 98 (02) : 154 - 163
[5] Personalized medicine for HER2 positive breast cancer
Tamura, Kenji
ANNALS OF ONCOLOGY, 2016, 27
[6] Characterization of HER2 positive breast cancer in Tunisia
Yaiche, R.
Houcine, Y.
Saidi, E.
Saadallah, F.
Kamoun, S.
Meddeb, K.
Driss, M.
VIRCHOWS ARCHIV, 2024, 485 : S210 - S210
[7] Treatment of HER2 positive breast cancer patients
Matos, Erika
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (03): : 236 - 245
[8] HER2 POSITIVE BREAST CANCER - BIOLOGY AND RESISTANCE
Penault-Llorca, Frederique
BREAST, 2019, 48 : S31 - S31
[9] Adjuvant therapy in breast cancer HER2 positive
Olivito, V.
De Simone, R.
La Gattuta, G.
Lucia, M.
Dima, G.
Talarico, R.
Filippelli, G.
ANNALS OF ONCOLOGY, 2006, 17 : VII146 - VII146
[10] EARLY RELAPSE OF HER2 POSITIVE BREAST CANCER
Zelen, Teodora Brdar
Prica, Anja
Jovisevic, Marija
BREAST, 2023, 71 : S58 - S58